Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2022 and 2023.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2023
SYNGULON from Seraing, company number BE0521816349, closed financial year 2023 with a result of € -720,764 after tax. For that financial year SYNGULON recorded a gross margin of € 142,835 and equity of € 2.5 million. Compared with financial year 2022, the result moved from € -996,711 to € -720,764. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 19, 2024.
€ 2.5 million
▲ 3% vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -720,764
▲ 28 % less loss than in 2022
Profit after tax over the fiscal year.
€ 11,391
▲ € 9,892 vs 2022
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -721,243.
People and assets in 2023
9
▼ 1.2 vs 2022
Average over the fiscal year, from the social balance sheet.
€ 710,642
▼ 14% vs 2022
€ 79,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2023
€ 1.1 million
▼ 8% vs 2022
€ 127,310 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 427,799
▲ 52% vs 2022
Supplier invoices still open on the last day of the fiscal year.
€ 159,746
▼ 25% vs 2022
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|---|
| Gross margin | € 45,433 | € -6,910 | € 142,835 | ▲ € 149,745 |
| Profit after taxes | € -718,104 | € -996,711 | € -720,764 | ▲ € 275,947 |
| Equity | € 3,182,232 | € 2,445,521 | € 2,524,757 | ▲ 3% |
| Total debts | € 3,054,761 | € 3,061,594 | € 3,133,488 | ▲ 2% |
| Cash | € 538,100 | € 1,500 | € 11,391 | ▲ € 9,892 |
| Retained profit | € -753,768 | € -1,750,479 | € -721,243 | ▲ € 1 million |
| Bank debt | € 1,358,290 | € 1,248,419 | € 1,146,607 | ▼ 8% |
| Balance sheet total | € 6,236,993 | € 5,507,115 | € 5,658,245 | ▲ 3% |
| Employees (FTE) | 9 | 10.2 | 9 | ▼ 1.2 |
Key figures of SYNGULON, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
What happened to SYNGULON?
What happened at SYNGULON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
SYNGULON is active according to the CBE. Legal situation: Opening faillissement.
- Denis DUFRANE stepped down as director. NBB
- Jean-Pierre Delwart stepped down as director. NBB
- Philippe Gabant stepped down as director. NBB
- Guy Hélin stepped down as director. NBB
- New annual accounts for financial year 2023: loss of € 720,764. Source: NBB ↗
- Denis DUFRANE became a director. NBB
- XFIVE SCRL stepped down as director. NBB
- XFIVE SCRL became a director. NBB
In short
From € 718,104 loss in 2021 to € 720,764 loss in 2023.
On average € 15,900 of value added per employee in 2023.
A new publication or filing at SYNGULON? We notify you, reason included.
Follow SYNGULONDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2023 annual accounts
since 2021 · until 2023
Philippe Gabant
Managing director
since 2019 · until 2025
Denis DUFRANE
Director
since 2023 · until 2029
Guy Hélin
Managing director
Also active at: INTERNATIONAL PROFESSIONAL MANAGEMENT CONSULTANT BELGIQUE, Pôle GREENWIN, DNAVision
since 2019 · until 2025
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Rue du Bois St-Jean 15/1
4102 Seraing
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →AQUILON PHARMACEUTICALS
€ 1.3 million gross margin · 2025
ARTESIA ENVIRONNEMENT
€ 1 million gross margin · 2025
ALPHACOMSOLUTION
€ 558,735 gross margin · 2025
Société internationale pour l'étude de l'adhésion médicamenteuse
ALIZES PHARMA
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0521.816.349
- VAT number
- BE 0521.816.349
- Registered office
- Rue du Bois St-Jean 15/1, 4102 Seraing
- Names & denominations
- SYNGULON
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 7 March 2013
- Peppol
- Not registered
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied